ArticleFrontiers in medicine2026
Integrated therapy including acupuncture in a patient with long-term survival from spinal cord metastases of ALK-positive lung adenocarcinoma: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer remains a leading cause of cancer mortality globally. Spinal cord metastases (SCMs) signify an advanced disease stage with a particularly dire prognosis, primarily due to severe neurological deficits and subsequent life-threatening complications. While modern systemic therapies can control tumor growth, they often inadequately address the critical issue of neurological recovery, which may be the key determinant of ultimate survival. Case presentation: A 47-years-old female with ALK-positive lung adenocarcinoma developed multiple SCMs. Following post-SCM systemic therapy, tumor burden decreased but limb strength deteriorated. Adjunctive acupuncture then led to improved muscle strength and quality of life. Overall survival from SCM diagnosis was over 9 months. Conclusion: This case highlights neurological recovery as a key goal in SCMs. Integrating acupuncture with standard therapy shows promise for improving function and outcomes, warranting further study.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.